Bank Of Montreal Mirati Therapeutics, Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$41.99 - $62.38 $27.3 Million - $40.6 Million	651,314 New	651,314 $38.3 Million
Q2 2022 Aug 11, 2022	BUY	$39.16 - $88.71 $15.6 Million - $35.3 Million	398,480 Added 199.36%	598,362 $41.3 Million
Q1 2022 May 12, 2022	BUY	$75.82 - $150.97 $15.2 Million - $30.2 Million	199,882 New	199,882 $17.1 Million
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $1.02 Million - $1.48 Million	-7,753 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $11.3 Million - $15.1 Million	-85,252 Reduced 91.66%	7,753 $1.35 Million
Q2 2021 Aug 12, 2021	BUY	$144.0 - $179.73 $13.4 Million - $16.7 Million	93,005 New	93,005 $15.2 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.